06/05/2013
https://www.congress.gov...
"So I am going to give a legislator's response and then yield to the former Cabinet member."
"So what happened was that this brilliant idea of ours did not seem so brilliant to the generic drug industry which did not want the patent life extended."
"That is a great question."
"I am really grateful that this Senate Committee is the first to hold a hearing on our report."